Could melatonin help kids with PTSD sleep better?
NCT ID NCT07418554
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a slow-release form of melatonin can improve sleep in 120 children and adolescents (ages 2-17.5) with PTSD who have significant sleep disturbances. Participants will receive either melatonin or a placebo for 13 weeks. The study aims to see if melatonin increases total sleep time and reduces PTSD symptoms, daytime problems, and caregiver stress.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- prolonged-release melatonin
- What this could lead to
- If it works, this could provide a safe, effective treatment for sleep problems in children with PTSD, improving their daytime functioning and mental health.
- What could go wrong
- This is an early-stage trial with only 120 participants. Melatonin may not work for PTSD-related sleep issues, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CURRENT SIGNIFICANT SLEEP DISTURBANCES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple checklist forecast PTSD after critical illness?
- Can a psychedelic drug help heal trauma? a small trial puts psilocybin to the test
- Intensive therapy during a hospital stay may boost recovery for young trauma survivors
- Could trauma history sabotage epilepsy surgery? a new study investigates
- Could MDMA help heal PTSD in soldiers? new trial investigates
- Psychedelic-Assisted therapy targets Gut-Brain link in trauma depression